Home > M&A deals 2020 > UNION therapeutics A/S acquires LEO PDE4 Inhibitor
Divestiture · Life Science · July 2020

UNION therapeutics A/S acquires LEO PDE4 Inhibitor

On July 21, 2020, UNION therapeutics A/S acquired LEO PDE4 Inhibitor, a life science company in Denmark, from LEO Pharma AS.

Deal at a glance

AnnouncedJuly 21, 2020 TypeDivestiture TargetLEO PDE4 Inhibitor Buyer UNION therapeutics A/S Seller LEO Pharma AS SectorLife Science LocationDenmark ValueMembers only

Target company

LEO PDE4 Inhibitor
Denmark
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

UNION therapeutics A/S
Company · 1 deal on record
  • 1st transaction in life science
  • 1st transaction in Denmark
1deals, all time
1in this sector
2020latest

Seller

LEO Pharma AS
Company · 2 deals on record
2investments
1in this sector
1exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Chr. Olesen Synthesis A/SSame sector and country · Oct 2026
Intomics A/SSame sector and country · May 2022

Questions about this deal

Who acquired LEO PDE4 Inhibitor?UNION therapeutics A/S acquired LEO PDE4 Inhibitor on July 21, 2020.

Who sold LEO PDE4 Inhibitor?LEO Pharma AS was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).